News
LFCR
8.30
-5.47%
-0.48
Craig-Hallum Reaffirms Their Buy Rating on Lifecore Biomedical (LFCR)
TipRanks · 2d ago
Stock Picks From Seeking Alpha's June 2025 New Analysts
Seeking Alpha · 3d ago
Weekly Report: what happened at LFCR last week (0630-0704)?
Weekly Report · 4d ago
Weekly Report: what happened at LFCR last week (0623-0627)?
Weekly Report · 06/30 09:17
With Lifecore Biomedical Up 23%, Insider Buyers Count Their Returns
Simply Wall St · 06/25 11:30
Weekly Report: what happened at LFCR last week (0616-0620)?
Weekly Report · 06/23 09:16
Lifecore Biomedical: Inflecting Financials Over Next 3 Years
Seeking Alpha · 06/18 07:27
Lifecore Signs 10-Year Manufacturing Deal To Support Novel Ophthalmic Therapy
NASDAQ · 06/18 03:40
Craig-Hallum Sticks to Their Buy Rating for Lifecore Biomedical (LFCR)
TipRanks · 06/17 13:16
Lifecore signs new 10-year commercial manufacturing, supply agreement
TipRanks · 06/17 11:20
Lifecore Signs 10-Year Deal to Make Eye Drug, Boosting Long-Term Revenue Growth Prospects
Benzinga · 06/17 11:01
LIFECORE BIOMEDICAL SIGNS NEW 10-YEAR COMMERCIAL MANUFACTURING AND SUPPLY AGREEMENT WITH KEY EXISTING CUSTOMER
Reuters · 06/17 11:00
Weekly Report: what happened at LFCR last week (0609-0613)?
Weekly Report · 06/16 09:17
Lifecore Receives Full Payment Early For $17 Mln Equipment Sale
NASDAQ · 06/12 15:22
Craig-Hallum Remains a Buy on Lifecore Biomedical (LFCR)
TipRanks · 06/12 13:15
Lifecore receives accelerated payment of $10M in proceeds from equipment sale
TipRanks · 06/12 11:10
LIFECORE BIOMEDICAL INC - RECEIVES REMAINING $10 MLN FROM SALE OF ISOLATOR FILLER
Reuters · 06/12 11:02
Press Release: Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale
Dow Jones · 06/12 11:00
Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale
Barchart · 06/12 06:00
Weekly Report: what happened at LFCR last week (0602-0606)?
Weekly Report · 06/09 09:17
More
Webull provides a variety of real-time LFCR stock news. You can receive the latest news about Lifecore Biomedical Inc through multiple platforms. This information may help you make smarter investment decisions.
About LFCR
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.